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✓Integral membrane protein, ubiquitously 
expressed and critical for  the CNS 
functioning.
✓FUNCTION: Vesicle fusion and Ca2+
modulation (Mendoza-Torreblanca et al., 
2013)
EPILEPSY
✓Affects around 1% population, 25% suffer 
drug-resistant epilepsy.
✓ SYMPTOMS:  Seizures, cognitive impairments, 
mood disorders.
✓ The SV2A decrease is present 
along all the epileptic process, 
even in early phases of the 
disease.
✓ The use of [18F]UCB-H is suitable to 
detect and evaluate the epileptic 
disease,  and to develop and 













KA (SALINE) IP 
INJECTION (15mg/kg)
(Hellier et al., 1998)
DAYS 30-45
First spontaneous crises 
DAYS 90-105
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